ECL- mPZ for Tooth structure

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Augusta University-Dental College of Georgia, Augusta, GA
Tooth structure+1 More
ECL- mPZ - Procedure
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

In this randomized clinical trial, the investigators are comparing two different approaches for Esthetic crown lengthening- a minimally invasive approach using piezoelectric (PZ) and a traditional open flap approach (OF).

Eligible Conditions

  • Tooth structure

Treatment Effectiveness

Study Objectives

1 Primary · 3 Secondary · Reporting Duration: BOP will be evaluated prior to surgery and 6 and 12 month after surgery

Month 12
Change on Bleeding on probing (BOP)
Month 12
Change clinical attachment level (CAL).
Month 12
Change of supracrestal width (cementoenamel junction to alveolar crest CEJ-AC)
Month 12
Change on Probing depth (PD)

Trial Safety

Trial Design

2 Treatment Groups

Control group: Crown lengthening using a traditional open-flap approach (OF).
1 of 2
Test group: Crown lengthening using a minimally invasive approach by piezoelectr...
1 of 2
Active Control
Experimental Treatment

36 Total Participants · 2 Treatment Groups

Primary Treatment: ECL- mPZ · No Placebo Group · N/A

Test group: Crown lengthening using a minimally invasive approach by piezoelectric (PZ).
Procedure
Experimental Group · 1 Intervention: ECL- mPZ · Intervention Types: Procedure
Control group: Crown lengthening using a traditional open-flap approach (OF).
Procedure
ActiveComparator Group · 1 Intervention: ECL-OF · Intervention Types: Procedure

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: bop will be evaluated prior to surgery and 6 and 12 month after surgery
Closest Location: Augusta University-Dental College of Georgia · Augusta, GA
Photo of georgia 1Photo of georgia 2Photo of georgia 3
2020First Recorded Clinical Trial
0 TrialsResearching Tooth structure
1 CompletedClinical Trials

Who is running the clinical trial?

Augusta UniversityLead Sponsor
191 Previous Clinical Trials
74,073 Total Patients Enrolled
Ahmed El-Awady, BDS, MS, PHDPrincipal InvestigatorAugusta University

Eligibility Criteria

Age 18+ · All Participants · 3 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
Patients with a gummy smile due to APE (Type 1B) in two or more maxillary anterior teeth.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.